Summit Partners Public Asset Management, LLC Crispr Therapeutics Ag Call Options Transaction History

Summit Partners Public Asset Management, LLC

$2.28 Billion
Q2 2024

Call Options

2 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $7.7 Million - $15.2 Million	-200,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$33.68 - $62.53 $6.74 Million - $12.5 Million	200,000 New	200,000 $8.48 Million

Others Institutions Holding CRSP

# of Institutions

499

Shares Held

56.8M

Call Options Held

1.7M

Put Options Held

1.8M

Capital International Investors Los Angeles, CA

7.87M
Shares

$408 Million
0.09% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$389 Million
3.35% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$154 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$154 Million
1.61% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$144 Million
0.0% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $4.05B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Account